Medications for Hiv1

43 results
  • Atripla (efavirenz, emtricitabine, and tenofovir disoproxil fumarate)

    (efavirenz, emtricitabine, and tenofovir disoproxil fumarate)
    Gilead Sciences Inc
    Usage: ATRIPLA® is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg, either as a complete regimen or in combination with other antiretroviral agents.
  • Atripla (efavirenz, emtricitabine, and tenofovir disoproxil fumarate)

    (efavirenz, emtricitabine, and tenofovir disoproxil fumarate)
    Physicians Total Care, Inc.
    Usage: ATRIPLA® is indicated for the treatment of HIV-1 infection in adults and pediatric patients aged 12 and older, either as a complete regimen or in combination with other antiretroviral agents.
  • Biktarvy

    (bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate)
    Gilead Sciences, Inc.
    Usage: BIKTARVY is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 14 kg, either as a complete regimen for those with no antiretroviral treatment history or as a replacement for those who are virologically suppressed on a stable regimen without resistance issues.
  • Amneal Pharmaceuticals NY LLC
    Usage: Darunavir, when combined with ritonavir and other antiretroviral agents, is indicated for the treatment of HIV-1 infection in patients aged 3 years and older.
  • Dovato

    (dolutegravir sodium and lamivudine)
    ViiV Healthcare Company
    Usage: DOVATO is indicated for the treatment of HIV-1 infection in adults and adolescents (12 years and older, weighing at least 25 kg) who are either treatment-naive or virologically suppressed on a stable regimen without known resistance issues.
  • Edurant

    (rilpivirine hydrochloride)
    Janssen Products, LP
    Usage: EDURANT is indicated for the treatment of HIV-1 in treatment-naïve patients aged 2 and older with specific viral loads. It is also used in combination with cabotegravir for short-term treatment in adults and adolescents who are virologically suppressed and require an oral lead-in or temporary oral therapy.
  • REMEDYREPACK INC.
    Usage: Efavirenz tablets, used with other antiretroviral agents, are indicated for treating HIV-1 infection in adults and pediatric patients aged at least 3 months, weighing at least 3.5 kg.
  • Aurobindo Pharma Limited
    Usage: Efavirenz capsules, in combination with other antiretroviral agents, are indicated for treating HIV-1 infection in adults and pediatric patients aged at least 3 months and weighing a minimum of 3.5 kg.
  • Macleods Pharmaceuticals Limited
    Usage: Efavirenz, in combination with other antiretroviral agents, is indicated for treating HIV-1 infection in adults and pediatric patients aged at least 3 months who weigh at least 3.5 kg.